Screener
4D Molecular Therapeutics FDMT Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by 4D Molecular Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: 4D Molecular Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 4:13 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211939
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value, 300,000,000 shares authorized at March 31, 2026 and December 31, 2025; 52,271,648 and 57,607,874 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively | 5 | 6 |
| Additional paid-in-capital | 1,237,075 | 1,221,235 |
| Accumulated other comprehensive gain (loss) | (180) | 727 |
| Accumulated deficit | (785,064) | (716,304) |
| Total stockholders’ equity | 451,836 | 505,664 |
| Total liabilities and stockholders’ equity | $512,905 | $566,711 |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is 4D Molecular Therapeutics's retained earnings?
- 4D Molecular Therapeutics (FDMT) reported retained earnings of -$785.06M in Q1 2026.
- How has 4D Molecular Therapeutics's retained earnings changed year-over-year?
- 4D Molecular Therapeutics's retained earnings decreased by 25.8% year-over-year, from -$624.17M to -$785.06M.
- What is the long-term trend for 4D Molecular Therapeutics's retained earnings?
- Over 5 years (2020 to 2025), 4D Molecular Therapeutics's retained earnings has grown at a 39.5% compound annual growth rate (CAGR), from -$135.68M to -$716.3M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about 4D Molecular Therapeutics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude